PGCM
ISEE

Prescott Group Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Prescott Group Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-60,036
Closed -$220K – 173
2017
Q1 		$220K Sell
60,036
-420,000
-87% -$1.77M 0.05% 153
2016
Q4 		$2.32M Buy
+480,036
New +$14.2M 0.49% 52

Other funds holding ISEE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Prescott Group Capital Management's ISEE Position: Q2 2017 in Review

Prescott Group Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2017, closing a stake of 60,036 shares — an estimated $220K sold.

Prescott Group Capital Management first reported a position in ISEE in Q4 2016 and held it in 2 quarters. The position peaked at $2.32M in Q4 2016. 77 funds tracked by Wall St. Rank hold ISEE as of Q2 2017.

  • Prescott Group Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Prescott Group Capital Management sold 60,036 IVERIC bio, Inc. Common Stock shares in Q2 2017, an estimated $220K.
  • Prescott Group Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2016 and held it in 2 quarters.
  • Prescott Group Capital Management's IVERIC bio, Inc. Common Stock position peaked at $2.32M in Q4 2016.
  • 77 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2017.

Based on Prescott Group Capital Management's 13F filing for Q2 2017, filed 20 Jul 2017.